Nebenwirkungen · Idelvion
IDELVION 250 IU powder and solvent for solution for injection IDELVION 500 IU powder and solvent for solution for injection IDELVION 1000 IU powder and solvent for solution for injection IDELVION 2000 IU powder and solvent for solution for injection IDELVION 3500 IU powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 7
HOS-133110 · Präparat HOS-097372
Summary of the safety profile Hypersensitivity or allergic reactions (which may include angioedema, burning and stinging at the infusion site, chills, flushing, generalised urticaria, headache, hives, hypotension, lethargy, nausea, restlessness, tachycardia, tightness of the chest, tingling, vomiting, wheezing) have been observed rarely and may in some cases progress to severe anaphylaxis (including shock). In some cases, these reactions have progressed to severe anaphylaxis, and they have occurred in close temporal association with development of factor IX inhibitors (see also section 4.4). Nephrotic syndrome has been reported following attempted immune tolerance induction in haemophilia B patients with factor IX inhibitors and a history of allergic reaction.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-16T12:26:00Z · SHA-256 ef78200b08bf55d95aea60fb381c9af4a418a7f01fe9473c5741f817c39a7895 · Passage 968c93a27601c7e0cc3a55ccb8049b5eac95356f4cd43aca0368b7c2d51ea69d · Zeichen 0–770 im Abschnitt